Acknowledgement
Supported by : Seoul National University Hospital
References
- Chang ML. Metabolic alterations and hepatitis C: from bench to bedside. World J Gastroenterol 2016;22:1461-1476 https://doi.org/10.3748/wjg.v22.i4.1461
- Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician 2006;74:756-762
- Park BJ, Lee YJ, Lee HR. Chronic liver inflammation: clinical implications beyond alcoholic liver disease. World J Gastroenterol 2014;20:2168-2175 https://doi.org/10.3748/wjg.v20.i9.2168
- Friedman SL. Liver fibrosis--from bench to bedside. J Hepatol 2003;38 Suppl 1:S38-S53
- Dietrich CG, Gotze O, Geier A. Molecular changes in hepatic metabolism and transport in cirrhosis and their functional importance. World J Gastroenterol 2016;22:72-88 https://doi.org/10.3748/wjg.v22.i1.72
- Starr SP, Raines D. Cirrhosis: diagnosis, management, and prevention. Am Fam Physician 2011;84:1353-1359
- Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-1022 https://doi.org/10.1002/hep.24199
- Korean Liver Cancer Study Group (KLCSG); National Cancer Center, Korea (NCC). 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol 2015;16:465-522 https://doi.org/10.3348/kjr.2015.16.3.465
- Yoon JH, Park JW, Lee JM. Noninvasive diagnosis of hepatocellular carcinoma: elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea Practice guidelines compared with other guidelines and remaining issues. Korean J Radiol 2016;17:7-24 https://doi.org/10.3348/kjr.2016.17.1.7
- Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419 https://doi.org/10.1016/S0016-5085(99)70506-8
- Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 1997;25:426-429 https://doi.org/10.1002/hep.510250228
- Dinant S, de Graaf W, Verwer BJ, Bennink RJ, van Lienden KP, Gouma DJ, et al. Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med 2007;48:685-692 https://doi.org/10.2967/jnumed.106.038430
- de Graaf W, van Lienden KP, van Gulik TM, Bennink RJ. (99m) Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy. J Nucl Med 2010;51:229-236 https://doi.org/10.2967/jnumed.109.069724
- Ge PL, Du SD, Mao YL. Advances in preoperative assessment of liver function. Hepatobiliary Pancreat Dis Int 2014;13:361-370 https://doi.org/10.1016/S1499-3872(14)60267-8
- Haimerl M, Verloh N, Fellner C, Zeman F, Teufel A, Fichtner-Feigl S, et al. MRI-based estimation of liver function: Gd-EOBDTPA-enhanced T1 relaxometry of 3T vs. the MELD score. Sci Rep 2014;4:5621
- Kudo M. Will Gd-EOB-MRI change the diagnostic algorithm in hepatocellular carcinoma? Oncology 2010;78 Suppl 1:87-93
- Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, et al. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT. J Gastroenterol 2012;47:1036-1047 https://doi.org/10.1007/s00535-012-0571-6
- Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 2010;255:459-466 https://doi.org/10.1148/radiol.10091388
- Frydrychowicz A, Lubner MG, Brown JJ, Merkle EM, Nagle SK, Rofsky NM, et al. Hepatobiliary MR imaging with gadoliniumbased contrast agents. J Magn Reson Imaging 2012;35:492-511 https://doi.org/10.1002/jmri.22833
- Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology 2015;275:97-109 https://doi.org/10.1148/radiol.14140690
- Tsuda N, Okada M, Murakami T. Potential of gadoliniumethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging. Invest Radiol 2007;42:242-247 https://doi.org/10.1097/01.rli.0000258058.44876.a5
- Shimizu J, Dono K, Gotoh M, Hasuike Y, Kim T, Murakami T, et al. Evaluation of regional liver function by gadolinium-EOBDTPA-enhanced MR imaging. Dig Dis Sci 1999;44:1330-1337 https://doi.org/10.1023/A:1026679113772
- Schmitz SA, Muhler A, Wagner S, Wolf KJ. Functional hepatobiliary imaging with gadolinium-EOB-DTPA. A comparison of magnetic resonance imaging and 153gadolinium-EOB-DTPA scintigraphy in rats. Invest Radiol 1996;31:154-160 https://doi.org/10.1097/00004424-199603000-00006
- Yoon JH, Lee JM, Paek M, Han JK, Choi BI. Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPAenhanced liver MR imaging. Eur Radiol 2016;26:1775-1782 https://doi.org/10.1007/s00330-015-3994-7
- Kim JY, Lee SS, Byun JH, Kim SY, Park SH, Shin YM, et al. Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents. AJR Am J Roentgenol 2013;201:322-331 https://doi.org/10.2214/AJR.12.9478
- Bae KE, Kim SY, Lee SS, Kim KW, Won HJ, Shin YM, et al. Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis 2012;30:617-622 https://doi.org/10.1159/000343092
- Storey P, Thompson AA, Carqueville CL, Wood JC, de Freitas RA, Rigsby CK. R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging 2007;25:540-547 https://doi.org/10.1002/jmri.20816
- Tang A, Tan J, Sun M, Hamilton G, Bydder M, Wolfson T, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 2013;267:422-431 https://doi.org/10.1148/radiol.12120896
- Bannas P, Kramer H, Hernando D, Agni R, Cunningham AM, Mandal R, et al. Quantitative magnetic resonance imaging of hepatic steatosis: validation in ex vivo human livers. Hepatology 2015;62:1444-1455
- Hernando D, Wells SA, Vigen KK, Reeder SB. Effect of hepatocyte-specific gadolinium-based contrast agents on hepatic fat-fraction and R2(*). Magn Reson Imaging 2015;33:43-50 https://doi.org/10.1016/j.mri.2014.10.001
- Meisamy S, Hines CD, Hamilton G, Sirlin CB, McKenzie CA, Yu H, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology 2011;258:767-775 https://doi.org/10.1148/radiol.10100708
- Hines CD, Frydrychowicz A, Hamilton G, Tudorascu DL, Vigen KK, Yu H, et al. T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging 2011;33:873-881 https://doi.org/10.1002/jmri.22514
- Yu H, McKenzie CA, Shimakawa A, Vu AT, Brau AC, Beatty PJ, et al. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 2007;26:1153-1161 https://doi.org/10.1002/jmri.21090
- Alustiza Echeverria JM, Castiella A, Emparanza JI. Quantification of iron concentration in the liver by MRI. Insights Imaging 2012;3:173-180 https://doi.org/10.1007/s13244-011-0132-1
- Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol 2009;104:1802-1829 https://doi.org/10.1038/ajg.2009.191
- Eggers H, Brendel B, Duijndam A, Herigault G. Dual-echo Dixon imaging with flexible choice of echo times. Magn Reson Med 2011;65:96-107 https://doi.org/10.1002/mrm.22578
- Kukuk GM, Hittatiya K, Sprinkart AM, Eggers H, Gieseke J, Block W, et al. Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis. Eur Radiol 2015;25:2869-2879 https://doi.org/10.1007/s00330-015-3703-6
- Katsube T, Okada M, Kumano S, Imaoka I, Kagawa Y, Hori M, et al. Estimation of liver function using T2* mapping on gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid enhanced magnetic resonance imaging. Eur J Radiol 2012;81:1460-1464 https://doi.org/10.1016/j.ejrad.2011.03.073
- Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T, et al. Liver parenchymal enhancement of hepatocytephase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 2009;30:1042-1046 https://doi.org/10.1002/jmri.21956
- Besa C, Bane O, Jajamovich G, Marchione J, Taouli B. 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function. Magn Reson Imaging 2015;33:1075-1082 https://doi.org/10.1016/j.mri.2015.06.013
- Nilsson H, Blomqvist L, Douglas L, Nordell A, Janczewska I, Naslund E, et al. Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis. Br J Radiol 2013;86:20120653 https://doi.org/10.1259/bjr.20120653
- Ding Y, Rao SX, Meng T, Chen C, Li R, Zeng MS. Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease. Eur Radiol 2014;24:959-966 https://doi.org/10.1007/s00330-014-3096-y
- Haimerl M, Schlabeck M, Verloh N, Zeman F, Fellner C, Nickel D, et al. Volume-assisted estimation of liver function based on Gd-EOB-DTPA-enhanced MR relaxometry. Eur Radiol 2016;26:1125-1133 https://doi.org/10.1007/s00330-015-3919-5
- Kamimura K, Fukukura Y, Yoneyama T, Takumi K, Tateyama A, Umanodan A, et al. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices. J Magn Reson Imaging 2014;40:884-889 https://doi.org/10.1002/jmri.24443
- Stikov N, Boudreau M, Levesque IR, Tardif CL, Barral JK, Pike GB. On the accuracy of T1 mapping: searching for common ground. Magn Reson Med 2015;73:514-522 https://doi.org/10.1002/mrm.25135
- Cassinotto C, Feldis M, Vergniol J, Mouries A, Cochet H, Lapuyade B, et al. MR relaxometry in chronic liver diseases: comparison of T1 mapping, T2 mapping, and diffusionweighted imaging for assessing cirrhosis diagnosis and severity. Eur J Radiol 2015;84:1459-1465 https://doi.org/10.1016/j.ejrad.2015.05.019
- Fan ST, Wang QS, Lo CM, Tam Yu KW, Lai EC, Wong J. Evaluation of indocyanine green retention and aminopyrine breath tests in patients with malignant biliary obstruction. Aust N Z J Surg 1994;64:759-762 https://doi.org/10.1111/j.1445-2197.1994.tb04534.x
Cited by
- The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study vol.19, pp.4, 2018, https://doi.org/10.3348/kjr.2018.19.4.568
- Correlation between Non-Alcoholic Fatty Liver Disease and Visceral Adipose Tissue in Non-Obese Chinese Adults: A CT Evaluation vol.19, pp.5, 2018, https://doi.org/10.3348/kjr.2018.19.5.923
- Age of Data in Contemporary Research Articles Published in Representative General Radiology Journals vol.19, pp.6, 2018, https://doi.org/10.3348/kjr.2018.19.6.1172
- Liver fat accumulation measured by high-speed T2-corrected multi-echo magnetic resonance spectroscopy can predict risk of cholelithiasis vol.26, pp.33, 2017, https://doi.org/10.3748/wjg.v26.i33.4996